Potential of stem cell therapy in intracerebral hemorrhage

Area of Science:

• Neuroscience
• Regenerative Medicine
• Neurology

Background:

• Spontaneous intracerebral hemorrhage (ICH) is a severe neurological condition with limited medical treatment options for functional recovery.
• Current treatments for ICH primarily involve surgical interventions, with a focus on minimally invasive hematoma evacuation.
• Significant advancements in medical interventions for post-ICH functional recovery are lacking.

Purpose of the Study:

• To summarize the pathophysiology and treatment targets of ICH.
• To introduce the therapeutic mechanisms of stem cells, including neurotrophy and neuroregeneration.
• To review preclinical and clinical studies on stem cell therapy for ICH.

Main Methods:

• Literature review of preclinical studies on stem cell therapy for ICH, analyzing cell types, administration timing, and routes.
• Compilation and review of completed/published and ongoing clinical trials evaluating stem cell therapy safety and efficacy in ICH patients.
• Discussion of challenges in translating preclinical findings to clinical applications.

Main Results:

• Stem cells offer therapeutic functions such as promoting neurotrophy and neuroregeneration.
• Preclinical studies provide a foundation for stem cell therapy in ICH models.
• Clinical trials indicate potential safety and efficacy, though further investigation is required.

Conclusions:

• Stem cell therapy presents a promising therapeutic strategy for intracerebral hemorrhage.
• Translational research is crucial to overcome limitations in applying preclinical findings to clinical practice.
• Future studies should focus on carefully selected patient groups for extensive clinical application.